NASDAQ:DH - Definitive Healthcare Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $46.25
  • Forecasted Upside: 28.29 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 8 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$36.05
▼ -1.95 (-5.13%)

This chart shows the closing price for DH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Definitive Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DH

Analyst Price Target is $46.25
▲ +28.29% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Definitive Healthcare in the last 3 months. The average price target is $46.25, with a high forecast of $53.00 and a low forecast of $34.00. The average price target represents a 28.29% upside from the last price of $36.05.

This chart shows the closing price for DH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 9 investment analysts is to hold stock in Definitive Healthcare.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 0 sell ratings
10/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/11/2021JPMorgan Chase & Co.Initiated CoverageNeutral$47.00High
10/11/2021Stifel NicolausInitiated CoverageBuy$53.00High
10/11/2021Raymond JamesInitiated CoverageMarket PerformHigh
10/11/2021Canaccord GenuityInitiated CoverageHold$46.00High
10/11/2021Deutsche Bank AktiengesellschaftInitiated CoverageHold$47.00High
10/11/2021Credit Suisse GroupInitiated CoverageNeutral$50.00High
10/11/2021Morgan StanleyInitiated CoverageEqual Weight$46.00High
10/11/2021BarclaysInitiated CoverageEqual Weight$47.00High
10/11/2021The Goldman Sachs GroupInitiated CoverageNeutral$34.00High
(Data available from 10/27/2016 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2021
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/27/2021

Current Sentiment

  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Definitive Healthcare logo
Definitive Healthcare Corp. provides healthcare commercial intelligence. The company's SaaS platform creates new paths in the healthcare market. Definitive Healthcare Corp. is based in FRAMINGHAM, Mass.
Read More

Today's Range

Now: $36.05
Low: $35.04
High: $38.16

50 Day Range

MA: N/A

52 Week Range

Now: $36.05
Low: $35.04
High: $50.30

Volume

328,901 shs

Average Volume

457,363 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Definitive Healthcare?

The following Wall Street analysts have issued research reports on Definitive Healthcare in the last year: Barclays PLC, Canaccord Genuity, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Raymond James, Stifel Nicolaus, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for DH.

What is the current price target for Definitive Healthcare?

8 Wall Street analysts have set twelve-month price targets for Definitive Healthcare in the last year. Their average twelve-month price target is $46.25, suggesting a possible upside of 28.3%. Stifel Nicolaus has the highest price target set, predicting DH will reach $53.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $34.00 for Definitive Healthcare in the next year.
View the latest price targets for DH.

What is the current consensus analyst rating for Definitive Healthcare?

Definitive Healthcare currently has 8 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in DH, but not buy more shares or sell existing shares.
View the latest ratings for DH.

What other companies compete with Definitive Healthcare?

How do I contact Definitive Healthcare's investor relations team?

Definitive Healthcare's physical mailing address is 550 COCHITUATE ROAD, FRAMINGHAM MA, 01701. The official website for Definitive Healthcare is www.definitivehc.com.